These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37868959)

  • 1. Biomarkers of sustained systemic inflammation and microvascular dysfunction associated with post-COVID-19 condition symptoms at 24 months after SARS-CoV-2-infection.
    Jacobs LMC; Wintjens MSJN; Nagy M; Willems L; Ten Cate H; Spronk HMH; van Kuijk SMJ; Ghossein-Doha C; Netea MG; Groh LA; van Petersen AS; Warlé MC
    Front Immunol; 2023; 14():1182182. PubMed ID: 37868959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19.
    Willems LH; Nagy M; Ten Cate H; Spronk HMH; Groh LA; Leentjens J; Janssen NAF; Netea MG; Thijssen DHJ; Hannink G; van Petersen AS; Warlé MC
    Thromb Res; 2022 Jan; 209():106-114. PubMed ID: 34922160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended coagulation profile of children with Long Covid: a prospective study.
    Di Gennaro L; Valentini P; Sorrentino S; Ferretti MA; De Candia E; Basso M; Lancellotti S; De Cristofaro R; De Rose C; Mariani F; Morello R; Lazzareschi I; Sigfrid L; Munblit D; Buonsenso D
    Sci Rep; 2022 Nov; 12(1):18392. PubMed ID: 36319840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent endothelial dysfunction in post-COVID-19 syndrome and its associations with symptom severity and chronic inflammation.
    Kuchler T; Günthner R; Ribeiro A; Hausinger R; Streese L; Wöhnl A; Kesseler V; Negele J; Assali T; Carbajo-Lozoya J; Lech M; Schneider H; Adorjan K; Stubbe HC; Hanssen H; Kotilar K; Haller B; Heemann U; Schmaderer C
    Angiogenesis; 2023 Nov; 26(4):547-563. PubMed ID: 37507580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidimensional Sleep Health Prior to SARS-CoV-2 Infection and Risk of Post-COVID-19 Condition.
    Wang S; Huang T; Weisskopf MG; Kang JH; Chavarro JE; Roberts AL
    JAMA Netw Open; 2023 May; 6(5):e2315885. PubMed ID: 37252741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perceived Cognitive Deficits in Patients With Symptomatic SARS-CoV-2 and Their Association With Post-COVID-19 Condition.
    Liu TC; Yoo SM; Sim MS; Motwani Y; Viswanathan N; Wenger NS
    JAMA Netw Open; 2023 May; 6(5):e2311974. PubMed ID: 37145596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults.
    Selvakumar J; Havdal LB; Drevvatne M; Brodwall EM; Lund Berven L; Stiansen-Sonerud T; Einvik G; Leegaard TM; Tjade T; Michelsen AE; Mollnes TE; Lund-Johansen F; Holmøy T; Zetterberg H; Blennow K; Sandler CX; Cvejic E; Lloyd AR; Wyller VBB
    JAMA Netw Open; 2023 Mar; 6(3):e235763. PubMed ID: 36995712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular Function, Systemic Inflammation, and Coagulation Activation 18 Months after COVID-19 Infection: An Observational Cohort Study.
    Willems LH; Jacobs LMC; Groh LA; Ten Cate H; Spronk HMH; Wilson-Storey B; Hannink G; van Kuijk SMJ; Ghossein-Doha C; Nagy M; Thijssen DHJ; van Petersen AS; Warlé MC
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Treatment With Nirmatrelvir and the Risk of Post-COVID-19 Condition.
    Xie Y; Choi T; Al-Aly Z
    JAMA Intern Med; 2023 Jun; 183(6):554-564. PubMed ID: 36951829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination after developing long COVID: Impact on clinical presentation, viral persistence, and immune responses.
    Nayyerabadi M; Fourcade L; Joshi SA; Chandrasekaran P; Chakravarti A; Massé C; Paul ML; Houle J; Boubekeur AM; DuSablon C; Boudreau V; Bovan D; Darbinian E; Coleman EA; Vinci S; Routy JP; Hétu PO; Poudrier J; Falcone EL
    Int J Infect Dis; 2023 Nov; 136():136-145. PubMed ID: 37717649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between fatigue and depressive symptoms in persons with post-COVID-19 condition: a post hoc analysis.
    Teopiz KM; Kwan ATH; Le GH; Guo Z; Badulescu S; Ceban F; Meshkat S; Di Vincenzo JD; d'Andrea G; Cao B; Ho R; Rhee TG; Dev DA; Phan L; Subramaniapillai M; Mansur RB; Rosenblat JD; McIntyre RS
    Curr Med Res Opin; 2024 Jul; 40(7):1203-1209. PubMed ID: 38860901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Limitations and Exercise Intolerance in Patients With Post-COVID Condition: A Randomized Crossover Clinical Trial.
    Tryfonos A; Pourhamidi K; Jörnåker G; Engvall M; Eriksson L; Elhallos S; Asplund N; Mandic M; Sundblad P; Sepic A; Rullman E; Hyllienmark L; Rundqvist H; Lundberg TR; Gustafsson T
    JAMA Netw Open; 2024 Apr; 7(4):e244386. PubMed ID: 38573638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-COVID-19 Condition in Children 6 and 12 Months After Infection.
    Dun-Dery F; Xie J; Winston K; Burstein B; Gravel J; Emsley J; Sabhaney V; Zemek R; Berthelot S; Beer D; Kam A; Freire G; Mater A; Porter R; Poonai N; Moffatt A; Dixon A; Salvadori MI; Freedman SB;
    JAMA Netw Open; 2023 Dec; 6(12):e2349613. PubMed ID: 38153737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence, pathophysiology, prediction and health-related quality of life of long COVID: study protocol of the longitudinal multiple cohort CORona Follow Up (CORFU) study.
    Ghossein-Doha C; Wintjens MSJN; Janssen EBNJ; Klein D; Heemskerk SCM; Asselbergs FW; Birnie E; Bonsel GJ; van Bussel BCT; Cals JWL; Ten Cate H; Haagsma J; Hemmen B; van der Horst ICC; Kietselaer BLJH; Klok FA; de Kruif MD; Linschoten M; van Santen S; Vernooy K; Willems LH; Westerborg R; Warle M; van Kuijk SMJ
    BMJ Open; 2022 Nov; 12(11):e065142. PubMed ID: 36446465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of post COVID-19 condition symptoms: a longitudinal study in the Belgian population.
    Nayani S; Castanares-Zapatero D; De Pauw R; Van Cauteren D; Demarest S; Drieskens S; Cornelissen L; Devleesschauwer B; De Ridder K; Charafeddine R; Smith P
    BMJ Open; 2023 Oct; 13(10):e072726. PubMed ID: 37802617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
    Ballouz T; Menges D; Kaufmann M; Amati R; Frei A; von Wyl V; Fehr JS; Albanese E; Puhan MA
    PLoS One; 2023; 18(2):e0281429. PubMed ID: 36812215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early antibody treatment, inflammation, and risk of post-COVID conditions.
    Gebo KA; Heath SL; Fukuta Y; Zhu X; Baksh S; Abraham AG; Habtehyimer F; Shade D; Ruff J; Ram M; Laeyendecker O; Fernandez RE; Patel EU; Baker OR; Shoham S; Cachay ER; Currier JS; Gerber JM; Meisenberg B; Forthal DN; Hammitt LL; Huaman MA; Levine A; Mosnaim GS; Patel B; Paxton JH; Raval JS; Sutcliffe CG; Anjan S; Gniadek T; Kassaye S; Blair JE; Lane K; McBee NA; Gawad AL; Das P; Klein SL; Pekosz A; Bloch EM; Hanley D; Casadevall A; Tobian AAR; Sullivan DJ;
    mBio; 2023 Oct; 14(5):e0061823. PubMed ID: 37724870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olfactory dysfunction as an early predictor for post-COVID condition at 1-year follow-up.
    Granvik C; Andersson S; Andersson L; Brorsson C; Forsell M; Ahlm C; Normark J; Edin A
    Brain Behav; 2024 Jun; 14(6):e3574. PubMed ID: 38841730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.